Lipid testing among patients beginning statin therapy in general practice in the United Kingdom

Value in Health

Volumn 11, Issue 5, 2008, Pages 933-938

  Phatak, Hemant ^a,c   Wentworth, Chuck ^b   Burke, Thomas A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Analytic Consulting Solutions   (United States)

^c NONE   (United States)

Author keywords

Cholesterol lipoproteins; Coronary heart disease risk; HDL cholesterol lipoproteins; Triglycerides

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; FEMALE; FOLLOW UP; GENERAL PRACTICE; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; POISSON DISTRIBUTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

EID: 52649178912     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00345.x     Document Type: Article

References (17)

1. Wood DA, Durrington P, McInnes G, et al. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1998 80 (Suppl. S1 29.
2. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005 91 (Suppl. 5 v1 52.
3. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice: summary. BMJ (Clinical research ed.) 2000 320 : 705 8.
4. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ (Clinical research ed.) 1991 302 : 766 8.
5. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
6. Anderson KM, Odell PM, Wilson PW, et al. Cardiovascular disease risk profiles. Am Heart J 1991 121 : 293 8.
7. Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ (Clinical research ed.) 2000 321 : 1322 5.
8. Phatak HM, Wentworth CV, Kocevar S, et al. Prevalence of mixed dyslipidemia and predictors of lipid abnormalities in patients treated with statins in general practice. Circulation 2007 115 : e253 (P145).
9. Olson KL, Bungard TJ, Tsuyuki RT. Cholesterol risk management: a systematic examination of the gap from evidence to practice. Pharmacotherapy 2001 21 : 807 17.
10. Northridge DB, Shandall A, Rees A, et al. Inadequate management of hyperlipidaemia after coronary bypass surgery shown by medical audit. Br Heart J 1994 72 : 466 7.
11. Bowker TJ, Clayton TC, Ingham J, et al. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events). Heart 1996 75 : 334 42.
12. Holt N, Johnson A, de Belder M. Patient empowerment in secondary prevention of coronary heart disease. Lancet 2000 356 : 314.
13. France MW, Kwok S, McElduff P, et al. Ethnic trends in lipid tests in general practice. QJM 2003 96 : 919 23.
14. Investing in General Practice: The New General Medical Services Contract. 2003.
15. NHS. Revisions to the GMS contract, 2006/07: Delivering Investment in General Practice. 2006.
16. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention. Eur Heart J 1998 19 : 1434 503.
17. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003 24 : 1601 10.